Tuberculosis (TB) Treatment
Tuberculosis (TB) Treatment

Treatment Range Hospital in Hyderabad offers comprehensive diagnosis and treatment for Tuberculosis (TB), including both pulmonary and extrapulmonary forms of the disease. Our experienced team of pulmonologists and infectious disease specialists ensures early detection, accurate testing, and personalized care to help patients recover fully while preventing the spread of infection. We are recognized as one of the trusted centers for TB treatment in Hyderabad.
Our approach includes detailed evaluation using chest X-rays, sputum tests, CBNAAT, and blood investigations to confirm the type and severity of TB. Patients receive a customized anti-tuberculosis treatment (ATT) plan following national guidelines, with close monitoring to ensure medication adherence and manage side effects. For complex or drug-resistant cases, we offer advanced therapies and inpatient care as needed.
If you are looking for effective and affordable TB treatment in Hyderabad, Treatment Range Hospital provides ethical, expert, and supportive care in a safe and well-equipped environment. Our goal is to cure the disease completely while promoting awareness and long-term health in every patient.
- Your 6 - Phase health Process
Your Complete Tuberculosis (TB) Treatment Journey
🔍 Phase 1: Symptom Identification
- Persistent cough for more than 2–3 weeks
- Coughing up blood or sputum
- Fever and night sweats
- Unexplained weight loss
- Fatigue and weakness
- Chest pain or difficulty breathing
🩺 Phase 2: OPD Consultation & Medical Evaluation
- Medical history and symptom review
- Physical examination
- Assessment of risk factors (contact with TB patient, past TB, immune status)
🔬 Phase 3: Identifying the Type & Drug Sensitivity
- Pulmonary vs. extrapulmonary TB
- Drug-sensitive vs. Drug-resistant TB
- Multi-drug resistant (MDR-TB) or extensively drug-resistant (XDR-TB) testing through Line Probe Assay or culture
🧪 Phase 4: Diagnosis
- Sputum microscopy and culture (to detect TB bacteria)
- Chest X-ray (to check for lung lesions)
- CB-NAAT (Cartridge Based Nucleic Acid Amplification Test)
- Mantoux test (Tuberculin skin test)
- Blood tests (CBC, ESR) and HIV test (as co-infection is common)
💊 Phase 5: Treatment Plan
- Intensive phase (2 months): Isoniazid, Rifampicin, Pyrazinamide, Ethambutol
- Continuation phase (4 months): Isoniazid and Rifampicin
- Longer treatment (up to 18–24 months) with second-line drugs
- Isolation (initially) to prevent spread
- Nutritional support, counseling, and HIV co-treatment if applicable
📅 Phase 6: Monitoring & Follow-Up
- Monthly sputum tests to assess response
- Monitor for side effects of medication (hepatitis, vision changes, etc.)
- Avoid NSAIDs oNutritional supplementationr harmful medications
- Follow-up chest X-ray (if needed)
- Completion of full course is essential to prevent relapse or resistance
- Post-treatment monitoring for recurrence (at 6 and 12 months)
Insurance Support










- Why Choose Us
Why patients trust us with their care
- Patient Testimonials
Patient stories of care and recovery










- Frequently Asked Questions
Helping you understand Our healthcare
Tuberculosis is a contagious infection caused by the bacteria Mycobacterium tuberculosis. It primarily affects the lungs but can also involve other parts of the body such as the brain, spine, and kidneys.
TB spreads through the air when an infected person coughs, sneezes, speaks, or sings. It is not spread by touching, sharing food, or physical contact.
Persistent cough (more than 2–3 weeks)
Coughing up blood or mucus
Fever and night sweats
Weight loss and fatigue
Chest pain or breathing difficulty
Yes. TB can relapse if the full course is not completed or if the immune system is weak. Follow-up after treatment is important to detect and treat any recurrence early.
Early diagnosis and complete treatment of TB patients
BCG vaccination for children
Good ventilation and sunlight in homes and workplaces
Wearing a mask and covering the mouth while coughing or sneezing
Regular screening for high-risk groups (HIV patients, healthcare workers, etc.)